Most Recent
Monster Energy settles trade mark fight with PepsiCo over popular snack food
A three-year court battle over PepsiCo's Monster Munch trade mark has been resolved, with Monster Energy negotiating the removal of some beverage products that would have been covered by the mark.C
Net-a-Porter loses challenge to The Iconic’s ‘Considered’ trade mark
The Iconic has defeated a challenge to the online fashion retailer's application to trade mark ‘Considered’ for sustainable or ethically sourced products, with IP Australia rejecting Net-a-Porter's argument that the label has not been used in the sense required under the Trade Marks Act.
End of the road for Hells Angels in fight for damages against Redbubble
The High Court has declined to step in after Hells Angels' award of $78,000 in damages for online marketplace Redbubble's infringement of its trade marks was slashed to just $100, bringing to an end an IP fight that has stretched on for nearly a decade.
‘Industrial scale misuse’: Fortescue sues former exec’s green iron start-up Element Zero
Fortescue has brought legal action against start-up Element Zero and three former employees, alleging “industrial scale misuse” of the Western Australian mining company's confidential information.
Pfizer calls out ‘impermissible fishing expedition’ in fight over Enbrel biosimilar
Drug giant Pfizer has blasted Samsung Bioepis' “fishing expedition” in its suit alleging infringement of the patent for its blockbuster arthritis drug Enbrel, telling the court the Korean biotech should not be allowed to dig for new grounds of invalidity.  
Neurim’s claim for additional damages survives in Circadin patent case
A judge has upheld Neurim Pharmaceutical’s claim for additional damages against two generic drug companies found to have infringed its patent for insomnia drug Circadin, despite the company's failure to comply with an earlier ruling.
Otsuka defends validity of injectable Abilify patent, accuses Sun Pharma of infringement
Otsuka Pharmaceutical has hit back at suit filed by Indian generics company Sun Pharma seeking to invalidate its patent for blockbuster antipsychotic Abilify, filing a cross-claim seeking to restrain Sun Pharma from infringing the patent with a generic version of the drug.
Law firm loses challenge to Glaxo’s term extension for COPD patent
Drug giant Glaxo has succeeded in extending the term for a patent for a drug that treats chronic obstructive pulmonary disease and asthma, with a delegate rejecting arguments from law firm Banki Haddock Fiora that the application was incorrectly based on a patent that was no longer valid because of amendments.
Seven resurrects ‘7NOW’ trade mark in latest fight with 7-Eleven
Seven Network has partially succeeded in appealing a decision that revoked its rights to the '7NOW' trade mark for non-use, with the Full Court finding the broadcaster used the mark on its news promotion website.
Aristocrat can’t get docs yet for possible trade secrets suit
A judge has rejected Aristocrat’s bid for orders requiring competitor Light & Wonder to hand over documents to be placed “in an envelope” for speedy production should its appeal of a decision ordering that it produce the documents to Aristocrat for possible trade secrets suit fail.